Systemic Sclerosis Market: Evolving Therapies and Strategic Insights
Systemic sclerosis, commonly referred to as scleroderma, is a rare, chronic autoimmune disorder characterized by vascular dysfunction, immune activation, and progressive fibrosis affecting the skin and internal organs. It manifests in two primary forms—limited cutaneous systemic sclerosis and diffuse cutaneous systemic sclerosis—with the latter being more aggressive and linked to...
0 Comments 0 Shares 66 Views 0 Reviews